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Nocardia species are difficult to identify, a consequence of the ever increasing number
of species known and their homogeneous genetic characteristics. 16S rRNA analysis
has been the gold standard for identifying these organisms, but proteomic techniques
such as matrix-assisted laser desorption ionization-time of flight (MALDI-TOF MS) and
housekeeping gene analysis, have also been explored. One hundred high (n = 25),
intermediate (n = 20), and low (n = 55) prevalence (for Spain) Nocardia strains
belonging to 30 species were identified via 16S rRNA and MALDI-TOF MS analysis.
The manufacturer-provided database MALDI Biotyper library v4.0 (5.627 entries, Bruker
Daltonik) was employed. In the high prevalence group (Nocardia farcinica, N. abscessus,
N. cyriacigeorgica and N. nova), the 16S rRNA and MALDI-TOF MS methods provided
the same identification for 76% of the strains examined. For the intermediate prevalence
group (N. brasiliensis, N. carnea, N. otitidiscaviarum and N. transvalensis complex), this
figure fell to 45%. In the low-prevalence group (22 species), these two methods were
concordant only in six strains at the species level. Tetra-gene multi-locus sequencing
analysis (MLSA) involving the concatemer gyrB-16S rRNA-hsp65-secA1 was used to
arbitrate between discrepant identifications (n = 67). Overall, the MLSA confirmed the
results provided at species level by 16S rRNA analysis in 34.3% of discrepancies,
and those provided by MALDI-TOF MS in 13.4%. MALDI-TOF MS could be a strong
candidate for the identification of Nocardia species, but only if its reference spectrum
database improves, especially with respect to unusual, recently described species and
species included in the described Nocardia complexes.
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INTRODUCTION
The members of Nocardia are branched Gram-positive opportunistic pathogens that live
in soils rich in organic matter. Nearly 90 species (Euzeby, 2013) cause clinical problems,
including cutaneous respiratory and systemic disease. Over 85% of all Nocardia species were
identified during the molecular era; previously, time-consuming phenotypic tests were used
(Brown-Elliott et al., 2015). Nowadays, the sequencing of the 16S rRNA gene is the most
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widespread method (Brown-Elliott et al., 2015). However, other
techniques based on protein profiling, such as matrix-assisted
laser desorption ionization-time of flight mass spectrometry
(MALDI-TOF MS), have increased their throughput and
potential use (Singhal et al., 2015) and have been shown useful
in the routine laboratory identification of Nocardia (Carbonnelle
et al., 2010).
Unfortunately, the MALDI-TOF MS identification harbors
limitations when only manufacturer-provided database has been
applied. It was stated in a literature review displaying low
values of correct Nocardia species assignment (≈15–53%) (Xiao
et al., 2016). In addition, the constantly increasing number of,
recognized Nocardia species means that the commercial MALDI-
TOF MS spectrum database for the genus can become outdated.
Both facts made that requiring laboratories to compile their own
libraries to get a successful identification (Brown-Elliott et al.,
2015; Buckwalter et al., 2016). However, this step could not be
feasible for many of the routine clinical laboratories, in which
MALDI-TOF MS has been widely introduced.
To achieve a successful species assignment in this genus,
molecular techniques as full-length 16S rRNA gene or multi-locus
sequence analysis (MLSA) have been undergone. Both are high
cost techniques that need on-site sequencing facilities, not being
available in most of the clinical laboratories (Xiao et al., 2016).
The present work compares the agreement between 16S rRNA
full gene and MALDI-TOF MS identification of Nocardia species
by using the current commercial database without in-house
supplementation (MALDI Biotyper software package version 3.1)
and identifies the shortcomings of the latter. This analysis
has been performed in a wide population of clinical Nocardia
strains constituted by species with different prevalence in Spain.
The tetra-gene MLSA (McTaggart et al., 2010) involving the
concatemer gyrB-16S rRNA-hsp65-secA1 was used to arbitrate
between discrepant identifications.
MATERIALS AND METHODS
Bacterial Strains, Amplifications, and
Sequencing
The bacteria examined in this work were 100 Nocardia strains
recovered from clinical samples (84 of respiratory origin, 6
cutaneous, 2 from the central nervous system and 8 from
other tissues) sent to our reference centre (Spanish National
Centre for Microbiology) from different hospitals between
2006 and 2014. These were identified by 16S rRNA analysis
(see below) as representing 30 Nocardia species, and were
selected for the present study since they represented more
and less commonly encountered members of the genus. All
these bacteria were incubated on buffered charcoal yeast extract
agar (BCYE) or Columbia 5% sheep blood agar at 37◦C for
at least 48 h (i.e., until growth was clearly visible). DNA
was extracted by the boiling method and amplifications of
the studied genes were performed using Ready-To-Go PCR
Beads (Amersham Biosciences, Buchinghamshire, UK). The
products were electrophoresed and purified using Exo SAP-
ITTM reagent (GE Healthcare, NJ, USA), and sequenced
by capillary electrophoresis in a ABI PRISM 3100 apparatus
(Applied Biosystems, Foster City, CA, USA) (Carrasco et al.,
2013) PCR primers and conditions are listed in Supplementary
Table S1.
16S rRNA Analysis
The received Nocardia strains were identified at the species level
by sequencing of the full-length 16S rRNA gene (size ∼1215 bp)
(with proofreading and editing as necessary). The obtained
sequences were compared with those in the GenBank database;
those showing≥99.6% similarity were deemed to be the same and
thus positively identified following CLSI MM18 guidelines (Petti
et al., 2008).
The BioEdit (Hall, 1999), CLUSTAL W (Thompson et al.,
1994), and Mega 6.0 computer programs were used to construct
a 16S rRNA phylogenetic tree (Tamura et al., 2013), employing
the neighbor joining method (Gascuel, 1997) and Kimura 2
parameter distances (Kimura, 1980) (Figure 1). The reliability of
the topologies was assessed by the bootstrap method with 1000
replicates.
Three groups were established according to the prevalence
of Nocardia species in Spain (Carrasco et al., 2013): 25 strains
representing Nocardia abscessus, N. cyriacigeorgica, N. farcinica
and N. nova were assigned to the high prevalence group, 20
strains representing N. brasiliensis, N. carnea, N. otitidiscaviarum,
and the N. transvalensis complex were assigned to the
intermediate prevalence group, and 55 (representing 22 less
frequently detected species) to the low prevalence group.
MALDI-TOF MS Identification
Protein samples were initially prepared as previously described
(Verroken et al., 2010). As seen with Mycobacterium spp., the
analysis of Nocardia by MALDI-TOF MS requires somewhat
complicated sample preparation (Dunne et al., 2014) due to the
presence of aliphatic acids in the cell wall (Xiao et al., 2016).
Despite this fact, three modifications of this extraction technique
were used (see Supplementary File S1): (i) mechanical disruption
with glass-beads; (ii) 10 min of sonication at 2500 oscillation
min-1 using a Mini Bead Beater (Biospec Products, Bartlesville,
OK) (both of these options preceding the rest of the Verroken
et al. method); and (iii) freezing for 24 h before proceeding to
protein extraction (performed after the boiling step described in
the Verroken et al. method).
Matrix-assisted laser desorption ionization-time of flight
spectra were randomly obtained from blind samples in the
linear positive mode at a laser with a frequency of 20 Hz
in the range of 2–20 kDa with a Microflex X instrument
using the FlexControl 3.3 (Bruker Daltonik, Bremen, Germany).
Each recorded spectrum is the result of six series of 40 single
laser shots in different locations, with user intervention only
when needed. Raw spectra of bacteria were explored using the
MALDI Biotyper 3.1 software package with default settings. The
database for identification was the reference Biotyper library
v4.0 5.627 MSP (Bruker Daltonik). In 2014, 5627 species were
included in this database (Piau et al., 2015). Identification
was performed with no custom database supplementation.
Identification scores (MALDI-TOF MS log scores) of ≥2.0 and
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FIGURE 1 | Phylogenetic tree based on 16S rRNA analysis of 100 Nocardia spp. strains (collected in Spain between 2006 and 2014), plus type strains.
The reliability of the topologies was assessed by the bootstrap method with 1000 replicates. The type strains, and the species for which full agreement was reached
between the 16S rRNA and MALDI-TOF MS methods, are represented in black. Strains with partially concordant identifications are shown in blue. Strains for which
no agreement was reached between the 16S rRNA and MALDI-TOF MS methods are shown in red.
1.7 –< 2.0 indicated species-level and genus-level identifications,
respectively, (Verroken et al., 2010; Hsueh et al., 2014).
Multi-Locus Sequence Analysis;
Arbitration between Discrepant
Identifications
Multi-locus sequencing analysis was performed when the
identifications made by the 16S rRNA and MALDI-TOF MS
methods did not agree (n = 67). The Nocardia identification
pattern of McTaggart et al. (2010) was used, but with four genes
instead of five; 16S rRNA, gyrB, hsp65, and secA1 genes. rpoB
was omitted given the reliability of this four-locus technique
compared to the five-locus technique (99.5%) (Liu et al.,
2011). Concatenated sequences of these four genes from each
discrepantly identified sample were aligned and a phylogenetic
tree constructed. When type strains were not available from
GenBank, those used in the McTaggart et al. study were
employed (McTaggart et al., 2010). N. elegans, N. takedensis, and
N. jiangxiensis lack a reference strain for all the genes in the MLSA
pattern; they do not appear, therefore, in the phylogenetic tree.
The results obtained were then compared against the discrepant
identifications made by the 16S rRNA and MALDI-TOF MS
methods.
Nucleotide Sequence Accession
Numbers
GenBank accession numbers for the sequences reported in this
study are KT933407-KT933625.
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TABLE 1 | Level of agreement between 16S rRNA and commercial MALDI-TOF MS database (Bruker Biotyper library v.4.0) identification of Nocardia
species.
Nocardia spp. (no. of strains) Agreement between 16S and
MALDI-TOF MS
No. of strains in the Bruker
database
High prevalence (n = 25)
Nocardia abscessus (n = 2) 2/2 2
N. cyriacigeorgica (n = 6) 5/6 16
N. farcinica (n = 8) 7/8 12
N. nova (n = 9) 5/9 2
Total (%) 19/25 (76.0%) 32
Intermediate prevalence (n = 20)
N. brasiliensis (n = 5) 3/5 1
N. carnea (n = 7) 1/7 1
N. otitidiscaviarum (n = 5) 5/5 6
N. transvalensis complex (n = 3) 0/3 1
Total (%) 9/20 (45%) 9
Low prevalence (n = 55)
22 Nocardia species: 5/55 45
-13 Nocardia species included in Bruker
database (n = 28)
5/23 45
-9 Nocardia species not included in Bruker
database (n = 27)
0 0
Total (%) 5/55 (9.1%) 45
RESULTS
Identification of Nocardia Species via
MALDI-TOF MS, Resolving
Discrepancies by MLSA
Table 1 shows the degree of overall agreement between 16S
and MALDI-TOF MS identification with manufacturer-provided
database (MALDI Biotyper library v4.0), and that within each
prevalence group according to its frequency in Spain (Carrasco
et al., 2013). The 16S rRNA method identified 79 out of 100
studied strains at the species level (Petti et al., 2008); 13 could
only be identified as Nocardia spp. Similarity values of 99.0–
99.5% were obtained for eight strains, not enough to assign
them to any Nocardia species, although they can be assumed
to belong to different Nocardia complexes (Schlaberg et al.,
2013).
For the 33 strains with concordant 16S rRNA and
MALDI-TOF MS identifications at species level, the
percentage similarity of the MLSA concatemer for each
strain with respect to the reference sequences in GenBank
reached 93.8–98.7%, 90.7–97.4%, and 90.1–100% for
the high, intermediate and low-prevalence subgroups,
respectively.
For the 67 strains, not concordant in the identification
made by the 16S rRNA and MALDI-TOF MS methods,
MLSA was performed. Among them, 34 strains were
concordant in genus but discrepantly identified at the
species level by the 16S rRNA and MALDI-TOF MS.
Their percentage similarities of the MLSA concatemer for
each strain with respect to the reference sequences for
high, intermediate and low-prevalence subgroups were of
94.4–98.9%, 96.9–97.6%, and 94.4–100.0%, respectively.
MLSA confirmed 7 identifications made by 16S rRNA and
9 identifications made by MALDI-TOF MS (Supplementary
Table S2).
Further 33 strains −25 from the low prevalent group-
were not concordant even at genus level by 16S rRNA
and MALDI-TOF MS. MLSA confirmed 16 identifications
made by 16S rRNA and none identification was made by
MALDI-TOF MS, as is shown in Supplementary Table S2.
Their percentage similarities of the MLSA concatemer for
each strain with respect to the reference sequences for high,
intermediate and low-prevalence subgroups were of 99.8%
(there was one strain only), 91.2–96.1 and 94.7–99.4%,
respectively (Supplementary Table S2). N. ignorata was
excluded from analysis given the strong presence of degenerate
positions in the reference strain partial 16S rRNA gene
(N. ignorata IMMIB R-1434T; GenBank accession no.
AJ303008).
Identification of Nocardia High
Prevalence Group
With respect to the high prevalence group, agreement between
the 16S rRNA and MALDI-TOF MS methods was reached
for 19 of the 25 strains examined. However, agreement
was complete only for the two strains of N. abscessus.
One of the six discrepant strains (identified as N. farcinica
by 16S rRNA) was not identified even at genus level by
the MALDI-TOF but laid together with its respective
type strain in the MLSA tree. Among the five remaining
strains, only one identification was confirmed by MLSA
(Figure 2).
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FIGURE 2 | Multi-locus sequencing analysis (MLSA)-based phylogenetic tree for 67 Nocardia spp. for which 16S rRNA and MALDI-TOF MS
identification was discordant, plus type strains. The reliability of the topologies was assessed by the bootstrap method with 1000 replicates. The type strains
are shown in black, and strains with partially concordant identifications are shown in blue. Strains for which no agreement was reached between the 16S rRNA and
MALDI-TOF MS methods are shown in red. Supplementary Table S2 contains further details.
Identification of Nocardia Intermediate
Prevalence Group
The agreement between the 16S rRNA and MALDI-
TOF MS methods was reached for 9 of the 20 strains
examined. However, while this agreement was complete
only for the strains of N. otitidiscaviarum, no agreement
was reached for any strain of the N. transvalensis complex.
For the 11 strains with discrepant identification, good
discrimination was reached by MLSA for N. brasiliensis,
but not N. transvalensis complex. In addition, MLSA was
unable to distinguish between N. carnea and N. flavorosea
(Figure 2).
Identification of Nocardia Low
Prevalence Group
16S rRNA and MALDI-TOF MS analysis only agreed in the
species identification of just five strains in this group: 2 out of
4 examples of N. asteroides, 1 out of 1 example of N. higoensis, 1
out of 2 of N. paucivorans, and 1 out of 2 N. testacea. For 25 of
the total of 55 strains of this group, it was able to confirm their
belonging to the genus Nocardia, but not for further 25 strains.
Only 13 of the 22 species in the low prevalence group
include their mass spectra (MS) in the Bruker database v
4.0 (1–3 MS profiles per species), covering 23 out of 50 of
the non-concordant strains of this group. With respect to
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the 13 species that were covered by the Bruker database,
MLSA provided confirmation in the identifications at species
level of 15 strains made by 16S rRNA analysis (MALDI-
TOF MS only provided identification for 4 strains). Indeed,
for N. cerradoensis, N. ignorata, and N. pneumoniae, MLSA
provided very good discrimination. MLSA was not able
to confirm the 16S rRNA identifications of N. wallacei or
N. blacklockiae (MALDI-TOF MS only provided unreliable
alternative identifications). MLSA tree was unable to distinguish
between N. brevicatena/N. paucivorans, N. arthritidis/N.
exalbida, and N. kruckzakiae/N. aobensis/N. africana/N.
nova, as identified by 16S rRNA (again, MALDI-TOF MS
only provided unreliable alternative identifications with log
scores <1.7).
Among the Nocardia strains belonging to non-covered species
by MALDI-TOF v.4.0 library (n = 27), MLSA tree confirmed
the identity of three strains – N. puris, N. rhamnosiphila, and
N. shimofusensis – previously identified by the 16S rRNA method,
but not by MALDI-TOF MS (Figure 2). No spectra were available
in the Bruker database for N. beijingensis, N. flavorosea, and
N. wallacei strains either, but these did locate to the same
MLSA branch as their corresponding reference sequence, thus
confirming to some degree their 16S rRNA identifications. No
MLSA confirmation could be made for the N. vinacea strains
identified as such by 16S rRNA analysis or as N. aobensis by
MALDI-TOF MS. When no pattern for a Nocardia sp. type
strain was available, only one strain returned a MALDI-TOF
MS log score of ≥2.0 allowing its identification at the species
level. Two of the strains with discrepant identifications, but with
MALDI-TOF MS log scores of 1.7–2.0, were identified by the
latter as outside of the Nocardia genus. It is noteworthy that
MALDI-TOF MS identified 11 Nocardia strains as Lactobacillus
spp., one with a log score of 1.989 (Supplementary Table S2).
However, four of the latter 11 strains also received an alternative
identification as belonging to the genus Nocardia (log score range
1.16–1.42).
Of the 13 strains identified as belonging only to Nocardia
sp. plus a type strain specification by the 16S rRNA method
(with 99.6% similarity to their comparators in the GenBank
database), although not identified as such by MALDI-TOF
MS with the current commercial database, six were fully
identified at the species level by the MLSA tree. Two strains
with a 16S rRNA-derived similarity of 99.0 and 99.5% to
N. pneumoniae clustered in the MLSA phylogenetic tree with the
N. pneumoniae DSM 44730 reference strain (GenBank accession
no. JF797313). Besides, one Nocardia sp. strain unreliably
identified by MALDI-TOF MS as N. paucivorans – but not
identified as such by 16S rRNA – clustered with N. paucivorans
DSM 44386 (GenBank accession number AF430041) in the
MLSA tree.
DISCUSSION
The MALDI-TOF MS method would appear to have a number
of shortcomings with respect to the identification of Nocardia
species. The Verroken et al. (2010) protein extraction protocol
appears to be adequate but not for all the strains. When the
unmodified method was used, 81 of the 100 strains were assigned
an identification (though not necessarily correct). When those
strains for which no identification was given were re-tested with
either the additional glass bead, the sonication, or the 48 h
freezing step, serviceable extracts were achieved for a further 10,
5, and 4 strains, respectively.
The agreement values reported by MALDI-TOF MS in an
earlier study involving Gram-positive bacilli such as Lactobacillus
spp., Listeria monocytogenes, and Rhodococcus spp. reached
a much higher ≥80% (Farfour et al., 2012). However, less
agreement was seen for 15 Kocuria (26.7%) and 74 Nocardia
strains (14.9%) (Hsueh et al., 2014). Other authors have also
indicated the inadequacy of the Bruker database for identifying
Nocardia species, leading to identification agreements between
the 16S rRNA and MALDI-TOF MS methods of just 15.6%
(Segawa et al., 2015), 53.0% (Khot et al., 2015), 42.0% (Buckwalter
et al., 2016), and none (Xiao et al., 2016) at the species level.
However, these values were improved to 90.6, 83.1, 90.0 and
95.0%, respectively, when in-house libraries with custom spectra
were included.
The present results reveal the relatively poor agreement
between the two methods in terms of Nocardia identification
at the species level. While agreement was reached for 76%
of the high-prevalence group species, this figure fell to 45
and 9.1%, for those of the intermediate and low prevalence
groups, respectively. The small number of MSs in the Bruker
database for the high (especially for N. nova) and intermediate
(especially for N. carnea and N. transvalensis complex) prevalence
species, and for unusual and recently described species, renders
the method unreliable because of the lack of identification
by MALDI-TOF MS with the commercial v. 4.0 database.
Moreover, in the present study, the identification of >10%
of the examined strains as members of Lactobacillus sp.,
as previously reported (Hsueh et al., 2014), is of particular
concern.
When identifications were discrepant in Nocardia species, the
MLSA method was used as an arbiter, to resolve the phylogenetic
resolution at the species level (Glaeser and Kämpfer, 2015).
When a discrepantly identified strain clustered with a type
strain in the MLSA phylogenetic tree this allowed its final
identification to be made (Vasileuskaya-Schulz et al., 2011).
A problem with MLSA is the inexistence of identification
breakpoints when using the present concatenated sequence.
In addition, there is no consensus housekeeping gene system
for use with Nocardia species, nor have codes been assigned
to alleles, nor does any sequence database exist. Even so, it
is the best method available for identifying Nocardia species,
but much more expensive and laborious than 16S rRNA or
MALDI-TOF MS. It is not, therefore, routinely used in health
laboratories.
CONCLUSION
Until the Bruker database is amplified, the MALDI-TOF MS
platforms with the Bruker Biotyper library v.4.0 cannot be
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considered a reliable technique as a routine method for
resolving Nocardia sp. identification. It is specially meaningful
for those unusual species -intermediate and low prevalence
groups-, newly described and species included the Nocardia
complexes. Until this occurs, health laboratories should consider
retaining the use of the full-length 16S rRNA gene sequencing
and the reference laboratories should confirm by MLSA this
identification.
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